IL13 and inflammatory bowel disease: Increased production of pro-inflammatory cytokines, including interferon gamma (IFN-γ), TNF-α, IL-1 and IL-13 further exacerbate damage to the intestinal mucosa, as occurs in inflammatory bowel disease (IBD) [38].